194 related articles for article (PubMed ID: 28885866)
1. Caspase inhibitors: a review of recently patented compounds (2013-2015).
Lee H; Shin EA; Lee JH; Ahn D; Kim CG; Kim JH; Kim SH
Expert Opin Ther Pat; 2018 Jan; 28(1):47-59. PubMed ID: 28885866
[TBL] [Abstract][Full Text] [Related]
2. Dual leucine zipper kinase (MAP3K12) modulators: a patent review (2010-2015).
Oetjen E; Lemcke T
Expert Opin Ther Pat; 2016 May; 26(5):607-16. PubMed ID: 27043251
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M; Muth F; Koch P; Laufer SA
Expert Opin Ther Pat; 2015; 25(8):849-72. PubMed ID: 25991433
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological caspase inhibitors: research towards therapeutic perspectives.
Kudelova J; Fleischmannova J; Adamova E; Matalova E
J Physiol Pharmacol; 2015 Aug; 66(4):473-82. PubMed ID: 26348072
[TBL] [Abstract][Full Text] [Related]
5. Novel therapies for glaucoma: a patent review 2007 - 2011.
Carta F; Supuran CT; Scozzafava A
Expert Opin Ther Pat; 2012 Jan; 22(1):79-88. PubMed ID: 22191414
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight inhibitors of Prolyl Oligopeptidase: a review of compounds patented from 2003 to 2010.
López A; Tarragó T; Giralt E
Expert Opin Ther Pat; 2011 Jul; 21(7):1023-44. PubMed ID: 21539473
[TBL] [Abstract][Full Text] [Related]
7. A novel method for evaluation and screening of caspase inhibitory peptides by the amino acid positional fitness score.
Yoshimori A; Takasawa R; Tanuma S
BMC Pharmacol; 2004 May; 4():7. PubMed ID: 15154972
[TBL] [Abstract][Full Text] [Related]
8. A Huntingtin-based peptide inhibitor of caspase-6 provides protection from mutant Huntingtin-induced motor and behavioral deficits.
Aharony I; Ehrnhoefer DE; Shruster A; Qiu X; Franciosi S; Hayden MR; Offen D
Hum Mol Genet; 2015 May; 24(9):2604-14. PubMed ID: 25616965
[TBL] [Abstract][Full Text] [Related]
9. Novel TACE inhibitors in drug discovery: a review of patented compounds.
Murumkar PR; DasGupta S; Chandani SR; Giridhar R; Yadav MR
Expert Opin Ther Pat; 2010 Jan; 20(1):31-57. PubMed ID: 20021284
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis.
Craig RA; Fox BM; Hu C; Lexa KW; Osipov M; Thottumkara AP; Larhammar M; Miyamoto T; Rana A; Kane LA; Yulyaningsih E; Solanoy H; Nguyen H; Chau R; Earr T; Kajiwara Y; Fleck D; Lucas A; Haddick PCG; Takahashi RH; Tong V; Wang J; Canet MJ; Poda SB; Scearce-Levie K; Srivastava A; Sweeney ZK; Xu M; Zhang R; He J; Lei Y; Zhuo Z; de Vicente J
J Med Chem; 2022 Dec; 65(24):16290-16312. PubMed ID: 36469401
[TBL] [Abstract][Full Text] [Related]
11. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
Marzaro G; Guiotto A; Chilin A
Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
[TBL] [Abstract][Full Text] [Related]
12. TBK1 inhibitors: a review of patent literature (2011 - 2014).
Yu T; Yang Y; Yin DQ; Hong S; Son YJ; Kim JH; Cho JY
Expert Opin Ther Pat; 2015; 25(12):1385-96. PubMed ID: 26293650
[TBL] [Abstract][Full Text] [Related]
13. Selective detection and inhibition of active caspase-3 in cells with optimized peptides.
Vickers CJ; González-Páez GE; Wolan DW
J Am Chem Soc; 2013 Aug; 135(34):12869-76. PubMed ID: 23915420
[TBL] [Abstract][Full Text] [Related]
14. Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).
Carradori S; Petzer JP
Expert Opin Ther Pat; 2015 Jan; 25(1):91-110. PubMed ID: 25399762
[TBL] [Abstract][Full Text] [Related]
15. A label-free LC/MS/MS-based enzymatic activity assay for the detection of genuine caspase inhibitors and SAR development.
Maillard MC; Dominguez C; Gemkow MJ; Krieger F; Park H; Schaertl S; Winkler D; Muñoz-Sanjuán I
J Biomol Screen; 2013 Sep; 18(8):868-78. PubMed ID: 23796689
[TBL] [Abstract][Full Text] [Related]
16. Proteasome inhibitor patents (2010 - present).
Metcalf R; Scott LM; Daniel KG; Dou QP
Expert Opin Ther Pat; 2014 Apr; 24(4):369-82. PubMed ID: 24450483
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Use of Peptide Based Substrates and Inhibitors of Apoptotic Caspases.
McStay GP
Methods Mol Biol; 2016; 1419():57-67. PubMed ID: 27108431
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA Reductase inhibitors: an updated review of patents of novel compounds and formulations (2011-2015).
Oliveira EF; Santos-Martins D; Ribeiro AM; Brás NF; Cerqueira NS; Sousa SF; Ramos MJ; Fernandes PA
Expert Opin Ther Pat; 2016 Nov; 26(11):1257-1272. PubMed ID: 27537201
[TBL] [Abstract][Full Text] [Related]
19. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models.
Kanthasamy AG; Anantharam V; Zhang D; Latchoumycandane C; Jin H; Kaul S; Kanthasamy A
Free Radic Biol Med; 2006 Nov; 41(10):1578-89. PubMed ID: 17045926
[TBL] [Abstract][Full Text] [Related]
20. Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.
Fournier JF; Clary L; Chambon S; Dumais L; Harris CS; Millois C; Pierre R; Talano S; Thoreau É; Aubert J; Aurelly M; Bouix-Peter C; Brethon A; Chantalat L; Christin O; Comino C; El-Bazbouz G; Ghilini AL; Isabet T; Lardy C; Luzy AP; Mathieu C; Mebrouk K; Orfila D; Pascau J; Reverse K; Roche D; Rodeschini V; Hennequin LF
J Med Chem; 2018 May; 61(9):4030-4051. PubMed ID: 29648825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
